Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$206.39 - $268.73 $665,814 - $866,922
3,226 New
3,226 $666,000
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $55,609 - $62,236
286 Added 15.01%
2,192 $430,000
Q2 2023

Aug 11, 2023

BUY
$183.71 - $210.25 $350,151 - $400,736
1,906 New
1,906 $401,000
Q3 2022

Nov 10, 2022

BUY
$182.44 - $250.54 $52,177 - $71,654
286 Added 16.05%
2,068 $407,000
Q2 2022

Aug 10, 2022

BUY
$204.13 - $302.4 $363,759 - $538,876
1,782 New
1,782 $381,000
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $223,571 - $316,846
-875 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $3.93 Million - $5.01 Million
-11,176 Reduced 92.74%
875 $330,000
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $2.24 Million - $2.75 Million
-6,011 Reduced 33.28%
12,051 $4.97 Million
Q2 2021

Aug 12, 2021

BUY
$294.17 - $371.65 $5.31 Million - $6.71 Million
18,062 New
18,062 $6.68 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.